Rani Therapeutics surges on Chugai licensing deal, private placement
Source: SeekingAlpha
2025-10-17 09:56:27 ET
More on Rani Therapeutics, Chugai Pharmaceutical Co., Ltd.
- Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation
- Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript
- Rani Therapeutics secures $60.3M in private placement to fund pipeline through 2028
- Trump’s 100% drug tariffs send pharma stocks lower
- Seeking Alpha’s Quant Rating on Rani Therapeutics
Read the full article on Seeking Alpha
For further details see:
Rani Therapeutics surges on Chugai licensing deal, private placement
Chugai Pharmaceutical
NASDAQ: CHGCF
CHGCF Trading
-0.72% G/L:
$59.755 Last:
1,694 Volume:
$60.2825 Open:
